Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R9XD
|
||||
Former ID |
DNC013101
|
||||
Drug Name |
H-Dmt-Tic-Lys(Z)-NH-CH2-Ph
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528411] | ||
Structure |
Download2D MOL |
||||
Formula |
C42H49N5O6
|
||||
Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=<br />O)OCC4=CC=CC=C4)C(=O)NCC5=CC=CC=C5)N)C)O
|
||||
InChI |
1S/C42H49N5O6/c1-28-21-34(48)22-29(2)35(28)24-36(43)41(51)47-26-33-18-10-9-17-32(33)23-38(47)40(50)46-37(39(49)45-25-30-13-5-3-6-14-30)19-11-12-20-44-42(52)53-27-31-15-7-4-8-16-31/h3-10,13-18,21-22,36-38,48H,11-12,19-20,23-27,43H2,1-2H3,(H,44,52)(H,45,49)(H,46,50)
|
||||
InChIKey |
MVEIALIQEDSFAK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528411] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528411] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.